SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:56S1 - FR0013154002 - Common Stock
204.7 EUR
-1.5 (-0.73%)
We assign a fundamental rating of 4 out of 10 to 56S1. 56S1 was compared to 22 industry peers in the Life Sciences Tools & Services industry. 56S1 has only an average score on both its financial health and profitability. 56S1 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year 56S1 was profitable.
- 56S1 had a positive operating cash flow in the past year.
- Each year in the past 5 years 56S1 has been profitable.
- In the past 5 years 56S1 always reported a positive cash flow from operatings.
1.2 Ratios
- 56S1 has a Return On Assets of 3.36%. This is comparable to the rest of the industry: 56S1 outperforms 40.91% of its industry peers.
- 56S1 has a Return On Equity of 6.55%. This is comparable to the rest of the industry: 56S1 outperforms 45.45% of its industry peers.
- 56S1 has a Return On Invested Capital (5.94%) which is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for 56S1 is in line with the industry average of 9.34%.
- The 3 year average ROIC (10.41%) for 56S1 is well above the current ROIC(5.94%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.36% | ||
| ROE | 6.55% | ||
| ROIC | 5.94% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
- 56S1's Profit Margin of 8.98% is in line compared to the rest of the industry. 56S1 outperforms 59.09% of its industry peers.
- In the last couple of years the Profit Margin of 56S1 has declined.
- With a decent Operating Margin value of 16.63%, 56S1 is doing good in the industry, outperforming 68.18% of the companies in the same industry.
- 56S1's Operating Margin has declined in the last couple of years.
- 56S1 has a Gross Margin (45.64%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of 56S1 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.63% | ||
| PM (TTM) | 8.98% | ||
| GM | 45.64% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 56S1 is creating some value.
- The number of shares outstanding for 56S1 has been increased compared to 1 year ago.
- The number of shares outstanding for 56S1 has been increased compared to 5 years ago.
- Compared to 1 year ago, 56S1 has an improved debt to assets ratio.
2.2 Solvency
- 56S1 has an Altman-Z score of 4.41. This indicates that 56S1 is financially healthy and has little risk of bankruptcy at the moment.
- 56S1 has a Altman-Z score of 4.41. This is in the better half of the industry: 56S1 outperforms 72.73% of its industry peers.
- The Debt to FCF ratio of 56S1 is 6.84, which is on the high side as it means it would take 56S1, 6.84 years of fcf income to pay off all of its debts.
- 56S1 has a Debt to FCF ratio (6.84) which is in line with its industry peers.
- 56S1 has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
- 56S1's Debt to Equity ratio of 0.50 is in line compared to the rest of the industry. 56S1 outperforms 59.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 6.84 | ||
| Altman-Z | 4.41 |
ROIC/WACC0.61
WACC9.72%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that 56S1 should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.05, 56S1 is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
- A Quick Ratio of 0.50 indicates that 56S1 may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.50, 56S1 is doing worse than 77.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.5 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 35.11% over the past year.
- Measured over the past 5 years, 56S1 shows a small growth in Earnings Per Share. The EPS has been growing by 4.19% on average per year.
- The Revenue has been growing slightly by 7.72% in the past year.
- The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%
3.2 Future
- Based on estimates for the next years, 56S1 will show a very strong growth in Earnings Per Share. The EPS will grow by 21.17% on average per year.
- The Revenue is expected to grow by 9.86% on average over the next years. This is quite good.
EPS Next Y29.12%
EPS Next 2Y23.48%
EPS Next 3Y22.85%
EPS Next 5Y21.17%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y9.86%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 47.49 indicates a quite expensive valuation of 56S1.
- Based on the Price/Earnings ratio, 56S1 is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
- 56S1 is valuated expensively when we compare the Price/Earnings ratio to 28.87, which is the current average of the S&P500 Index.
- 56S1 is valuated quite expensively with a Price/Forward Earnings ratio of 38.36.
- Based on the Price/Forward Earnings ratio, 56S1 is valued a bit more expensive than the industry average as 68.18% of the companies are valued more cheaply.
- When comparing the Price/Forward Earnings ratio of 56S1 to the average of the S&P500 Index (25.96), we can say 56S1 is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.49 | ||
| Fwd PE | 38.36 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 56S1 indicates a slightly more expensive valuation: 56S1 is more expensive than 72.73% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 56S1 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.19 | ||
| EV/EBITDA | 27.46 |
4.3 Compensation for Growth
- 56S1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as 56S1's earnings are expected to grow with 22.85% in the coming years.
PEG (NY)1.63
PEG (5Y)11.32
EPS Next 2Y23.48%
EPS Next 3Y22.85%
5. Dividend
5.1 Amount
- 56S1 has a yearly dividend return of 0.33%, which is pretty low.
- 56S1's Dividend Yield is comparable with the industry average which is at 0.48.
- Compared to an average S&P500 Dividend Yield of 1.82, 56S1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
- The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
- 56S1 pays out 25.37% of its income as dividend. This is a sustainable payout ratio.
- The dividend of 56S1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.37%
EPS Next 2Y23.48%
EPS Next 3Y22.85%
SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to 56S1.DE.
Can you provide the valuation status for SARTORIUS STEDIM BIOTECH?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (56S1.DE). This can be considered as Overvalued.
How profitable is SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for 56S1 stock?
The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (56S1.DE) is 47.49 and the Price/Book (PB) ratio is 4.94.
What is the earnings growth outlook for SARTORIUS STEDIM BIOTECH?
The Earnings per Share (EPS) of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 29.12% in the next year.